Elias Papatheodorou is the founder of HepaRegeniX. HepaRegeniX has raised $39M in total funding. Latest round: Series C. Backed by Vesalius Biocapital IV.
Elias Papatheodorou is the Chief Executive Officer of HepaRegeniX GmbH, a clinical-stage biotechnology company focused on therapies for liver diseases. He was appointed Chair of the Board of Directors in March 2022. He announced the company's €15 million Series C round in July 2024.
Full founder directory · Investor directory · Company funding database · Fundraising library